Adverum Biotechnologies Inc
NASDAQ:ADVM
Adverum Biotechnologies Inc
EPS (Diluted)
Adverum Biotechnologies Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adverum Biotechnologies Inc
NASDAQ:ADVM
|
EPS (Diluted)
-$6
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-36%
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$3
|
CAGR 3-Years
6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$15
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Adverum Biotechnologies Inc's EPS (Diluted)?
EPS (Diluted)
-6.9
USD
Based on the financial report for Mar 31, 2024, Adverum Biotechnologies Inc's EPS (Diluted) amounts to -6.9 USD.
What is Adverum Biotechnologies Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-36%
Over the last year, the EPS (Diluted) growth was -369%. The average annual EPS (Diluted) growth rates for Adverum Biotechnologies Inc have been -76% over the past three years , -44% over the past five years , and -36% over the past ten years .